Publikationen (77) Publikationen von Francisco Javier Jiménez Candil

2023

  1. Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7

  2. Clinical and economic outcomes of a systematic same-day discharge programme after pulmonary vein isolation: comparison between cryoballoon vs. radiofrequency ablation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 9

  3. Inteligencia Artificial aplicada a los datos obtenidos del seguimiento remoto del marcapasos: Justificación y diseño del estudio prospectivo IA-PACING

    I+S: Revista de la Sociedad Española de Informática y Salud, Núm. 155, pp. 13-16

  4. Prognostic Value of Heart Rate Preceding Ventricular Tachyarrhythmias Among ICD Patients With Left Ventricular Dysfunction

    JACC: Clinical Electrophysiology

  5. Spanish catheter ablation registry. 22nd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 910-921

  6. Spontaneous Variation of Ventriculo-Atrial Interval after Tachycardia Induction: Determinants and Usefulness in the Diagnosis of Supraventricular Tachycardias with Long Ventriculoatrial Interval

    Journal of Clinical Medicine, Vol. 12, Núm. 2

2022

  1. Decúbito de cables de marcapasos

    Los casos clínicos más docentes del año 2021 en cardiología (Medica Soluciones Innova)

  2. Outcome Analysis in Elective Electrical Cardioversion of Atrial Fibrillation Patients: Development and Validation of a Machine Learning Prognostic Model

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  3. Selection of the best of 2021 in cardiac arrhythmias

    REC: CardioClinics, Vol. 57, pp. S43-S47

  4. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

    Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453

  5. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 1, pp. 4-11

2021

  1. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 378-383

  2. Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  3. Outpatient ablation for atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 466-469

  4. Selection of the best of 2020 in cardiac arrhythmias

    REC: CardioClinics, Vol. 56, pp. 41-47